Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07312955) titled 'Solifenacin Plus Tadalafil vs Solifenacin Alone for Overactive Bladder in Females' on Dec. 16, 2025.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Ain Shams University

Condition: Overactive Bladder

Intervention: Drug: Solifenacin

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: May 15, 2025

Target Sample Size: 80

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/study/NCT07312955

Disclaimer: Curated by HT Syndication....